Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Disease of Immune System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06547944
What this trial is testing

Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNewly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableStudy completedNCT02891109
What this trial is testing

Regulatory B Cells and Chronic Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicRegulatory B Cells
University Hospital, Brest 36
Not applicableUnknownNCT05398133
What this trial is testing

Phenotype Assessment of Blood and Airway Eosinophils in Patients With COPD and Asthma

Who this might be right for
COPD AsthmaEosinophilic Asthma
Medical University of Warsaw 36
Not applicableLooking for participantsNCT06685744
What this trial is testing

TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial

Who this might be right for
Parkinson DiseaseMultiple SclerosisNeurologic Diseases, General
Fondazione Don Carlo Gnocchi ETS 300
Testing effectiveness (Phase 2)Study completedNCT00783367
What this trial is testing

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Who this might be right for
Follicular LymphomaMarginal Zone B-Cell LymphomaMALT Lymphoma+4 more
Abramson Cancer Center at Penn Medicine 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04749667
What this trial is testing

Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Who this might be right for
Multiple SclerosisProgressive Multiple Sclerosis
Haukeland University Hospital 18
Large-scale testing (Phase 3)Looking for participantsNCT07059000
What this trial is testing

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Kedrion S.p.A. 40
Not applicableUnknownNCT05174741
What this trial is testing

Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.

Who this might be right for
PneumoniaPulmonary FibrosisTuberculosis+2 more
Riphah International University 20
Not applicableWithdrawnNCT05304494
What this trial is testing

Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers

Who this might be right for
BreathlessnessCOPDAsthma+4 more
Sanome
Early research (Phase 1)Study completedNCT00749502
What this trial is testing

MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

Who this might be right for
Solid TumorsChronic Lymphocytic LeukemiaT-cell-prolymphocytic Leukemia
Tesaro, Inc. 113
Not applicableStudy completedNCT03151902
What this trial is testing

Detection of Viral Particels in Urticaria Patients

Who this might be right for
Urticaria Chronic
HaEmek Medical Center, Israel 10
Not applicableUnknownNCT02097381
What this trial is testing

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

Who this might be right for
HIV Infection
University of Roma La Sapienza 10
Testing effectiveness (Phase 2)Study completedNCT02581007
What this trial is testing

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+7 more
Northside Hospital, Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07189936
What this trial is testing

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

Who this might be right for
Post-Acute COVID-19 SyndromePostural Tachycardia Syndrome (POTS)SARS CoV 2 Infection+1 more
Vanderbilt University Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00077922
What this trial is testing

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphocyticChronic
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT03161028
What this trial is testing

Lipoic Acid for Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
VA Office of Research and Development 115
Early research (Phase 1)Study completedNCT00012207
What this trial is testing

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center 12
Post-approval studies (Phase 4)Study completedNCT01255644
What this trial is testing

Antiviral Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Medical University of Vienna 20
Large-scale testing (Phase 3)Study completedNCT00004772
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Center for Research Resources (NCRR) 90
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Next Page